Physician profile
Jitae Kim
NPI 1003376013
$1,865.82
in general payments reported to CMS, 2019-2025
9 companies · $889 in 2025
The $889 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $977 · 2025: $889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,317 · Travel and Lodging: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,317.15 |
| Travel and Lodging | $548.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $622.88 | 2024-2025 | |
| Abiomed | $408.40 | 2025 | |
| Pfizer INC. | $343.52 | 2024-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $193.01 | 2024 | Arcalyst |
| Edwards Lifesciences Corporation | $122.32 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $57.05 | 2024-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $48.51 | 2024 | Farxiga |
| Bridgebio Pharma, INC. | $47.11 | 2025 | Attruby |
| Merck Sharp & Dohme LLC | $23.02 | 2024 | Winrevair |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jitae Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.